In Vitro Susceptibility of Isolates of Borrelia Burgdorferi S.L. to Antimicrobial Agents

In the present study, we investigate the in vitro antimicrobial activity of macrolides, β-lactams and tetracycline against Borrelia burgdorferi s.l. clinical and tick isolates. Minimal inhibitory concentrations (MICs) were determined in normal growth condition and after pre-exposure of the strains to sub-MIC of the founder of each drug family. All the classes of tested antibiotics showed good antibacterial activity against all the borreliae isolates and there were no significant susceptibility differences among clinical and tick isolates. After pre-exposure of the strains to sub-MIC of erythromycin, cefoxitin and tetracycline, we observed that some strains of B. burgdorferi s.l. showed higher MIC values to both the pre-exposed drug and drugs of the same family. The less susceptibility of borreliae, in the last growth condition in vitro, could be one of the justifications of clinical results indicating the limited efficacy of these antibiotics in treatment of B. burgdoferi infections.

[1]  R. Baradaran-Dilmaghani,et al.  In vitro susceptibility of thirtyBorrelia strains from various sources against eight antimicrobial chemotherapeutics , 2005, Infection.

[2]  L. Ciceroni,et al.  Antigenic and genomic analysis of a Borrelia burgdorferi sensu stricto strain isolated from Ixodes ricinus ticks in Alto Adige-South Tyrol, Italy , 1998, European Journal of Epidemiology.

[3]  R. Sessa,et al.  Prevalence of Borrelia Burgdorferi Sensu Lato Genomospecies and of the Human Granulocytic Ehrlichiosis (HGE) Agent in Ixodes Ricinus Ticks Collected in the Area of Monti Lepini, Italy , 2003, International journal of immunopathology and pharmacology.

[4]  R. Wienecke,et al.  In Vitro Susceptibility Testing of Four Antibiotics against Borrelia burgdorferi: a Comparison of Results for the Three Genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi Sensu Stricto , 2003, Journal of Clinical Microbiology.

[5]  G. Wormser,et al.  Erythromycin Resistance in Borrelia burgdorferi , 2002, Antimicrobial Agents and Chemotherapy.

[6]  G. Fadda,et al.  Prevalence of IgG Antibodies against Borrelia Burgdorferi S.L. and Ehrlichia Phagocytophila in Sera of Patients Presenting Symptoms of Lyme Disease in a Central Region of Italy , 2002, International journal of immunopathology and pharmacology.

[7]  G. Caruso,et al.  Isolation and Characterization of Borrelia burgdorferi Sensu Lato Strains in an Area of Italy Where Lyme Borreliosis Is Endemic , 2001, Journal of Clinical Microbiology.

[8]  T. Wichelhaus,et al.  In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi. , 2001, International journal of antimicrobial agents.

[9]  N. Ippolito,et al.  Survey of Lyme disease in Abruzzo (Italy). , 2000, International journal of immunopathology and pharmacology.

[10]  T. Wichelhaus,et al.  Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates. , 2000, International journal of antimicrobial agents.

[11]  B. M. Jongh,et al.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  F. Strle,et al.  In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents , 1993, Antimicrobial Agents and Chemotherapy.

[13]  J. Jorgensen,et al.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi , 1993, Antimicrobial Agents and Chemotherapy.

[14]  S. Malawista,et al.  Lyme disease: recommendations for diagnosis and treatment. , 1991, Annals of internal medicine.